Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00052442
Status:
COMPLETED
Last Update Posted:
2021-08-25
First Post:
2003-01-24
Brief Title:
10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkins Lymphoma or Hodgkins Lymphoma
Sponsor:
Spectrum Pharmaceuticals Inc
Organization:
Spectrum Pharmaceuticals Inc
Organization Data
Organization:
Spectrum Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
CDR0000258425
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Spectrum Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Memorial Sloan Kettering Cancer Center | OTHER |
| National Cancer Institute NCI | NIH |